Evidence map›Paper›PMID 39456559›Full record

ArticleCancers2024

Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases.

Grigorios Gkasdaris, Julien Berthiller, Jacques Guyotat, Emmanuel Jouanneau, Clémentine Gallet, David Meyronet, Laure Thomas, Stéphanie Cartalat, Antoine Seyve, Jérôme Honnorat and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Grigorios GkasdarisDepartment of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.
Julien BerthillerDepartment of Research and Clinical Epidemiology-Public Health, Hospices Civils de Lyon, 69677 Bron, France.
Jacques GuyotatDepartment of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.
Emmanuel JouanneauDepartment of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.
Clémentine GalletDepartment of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.
David MeyronetFaculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.
Laure ThomasDepartment of Neuro-Oncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.
Stéphanie CartalatDepartment of Neuro-Oncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.
Antoine SeyveFaculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.
Jérôme HonnoratFaculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.ORCID 0000-0002-4721-5952
François DucrayFaculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.
Thiebaud PicartDepartment of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.ORCID 0000-0001-6494-6725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1,3-bis (2-chloroethyl)-1-nitrosoureaBCNUcarmustine waferpostoperative complicationprogressive glioblastomaprogressive high-grade gliomasurgical site infectionsurvival analysis

Identifiers

PMID39456559
PMCPMC11506748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.